Evidence map›Paper›PMID 32138244›Full record

ArticleMolecules (Basel, Switzerland)2020

Synthesis and Bioactivity Assessment of Novel Spiro Pyrazole-Oxindole Congeners Exhibiting Potent and Selective

Heba M Abo-Salem, Amr Nassrallah, Ahmed A F Soliman, Manal S Ebied, Mohamed E Elawady, Sayeda A Abdelhamid, Eslam R El-Sawy, Yazeed A Al-Sheikh, Mourad A M Aboul-Soud

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Nano-encapsulatedRSC advances · 2026
    Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Heba M Abo-SalemChemistry of Natural Compounds Department, National Research Centre, Dokki, 12622 Giza, Egypt.ORCID 0000-0003-3778-2272
Amr NassrallahBiochemistry Department, Faculty of Agriculture, Cairo University, 12613 Giza, Egypt.
Ahmed A F SolimanDrug Bioassay-Cell Culture Laboratory, Pharmacognosy Department, National Research Center, Dokki, 12622 Giza, Egypt.
Manal S EbiedChemistry of Natural Compounds Department, National Research Centre, Dokki, 12622 Giza, Egypt.
Mohamed E ElawadyMicrobial Biotechnology Department, National Research Centre, Dokki, 12622 Giza, Egypt.
Sayeda A AbdelhamidMicrobial Biotechnology Department, National Research Centre, Dokki, 12622 Giza, Egypt.
Eslam R El-SawyChemistry of Natural Compounds Department, National Research Centre, Dokki, 12622 Giza, Egypt.ORCID 0000-0002-7505-3356
Yazeed A Al-SheikhChair of Medical and Molecular Genetics Research, Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, P.O. Box 10219, Riyadh 11433, Saudi Arabia.
Mourad A M Aboul-SoudChair of Medical and Molecular Genetics Research, Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, P.O. Box 10219, Riyadh 11433, Saudi Arabia.ORCID 0000-0001-9395-0563

Funding

Deanship of Scientific Research, King Saud University Chair of Medical and Molecular Genetics Research
6 · The paper itself

Abstract

The present work aims to design and synthesize novel series of spiro pyrazole-3,3'-oxindoles analogues and investigate their bioactivity as antioxidant and antimicrobial agents, as well as antiproliferative potency against selected human cancerous cell lines (i.e., breast, MCF-7; colon, HCT-116 and liver, HepG-2) relative to healthy noncancerous control skin fibroblast cells (BJ-1). The mechanism of their cytotoxic activity has been also examined by immunoassaying the levels of key anti- and proapoptotic protein markers. The analytical and spectral data of the all synthesized target congeners were compatible with their structures. Synthesized compounds showed diverse moderate to powerful antimicrobial and antioxidant activities. Results of MTT assay revealed that seven synthesized compounds (i.e., 11a, 11b, 12a, 12b, 13b, 13c and 13h) particularly exhibited significant cytotoxicity against the three cancerous cell lines under investigation. Ranges of IC

Indexed as

Antineoplastic AgentsApoptosisHCT116 CellsHep G2 CellsHumansMCF-7 CellsOxindolesPyrazolesStructure-Activity RelationshipAntineoplastic AgentsOxindolespyrazolePyrazolesantiproliferative agentsapoptosisisatinspiro pyrazole-oxindoles

Identifiers

PMID32138244
PMCPMC7179167

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.